Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Zeillinger

Showing results (81-90 of 187) with videos related to

Pageof 19
Sort By:
Journal of the Society for Gynecologic Investigation|October 4, 2005
A common interleukin-6 promoter polymorphism in patients with vulvar cancerChristoph Grimm, Lucia Six, Caroline Tomovski, et al.
Journal of the Society for Gynecologic Investigation|November 26, 2002
Polymorphisms of the interleukin-1 gene cluster and ovarian cancerLukas A Hefler, Elisabeth Ludwig, Antje Lebrecht, et al.
Gynecologic Oncology|October 11, 2005
A polymorphism in the matrix metalloproteinase-1 gene promoter is associated with the prognosis of patients with ovarian cancerLucia Six, Christoph Grimm, Sepp Leodolter, et al.
Cancer Letters|December 14, 2001
Genetic alterations in endometrial hyperplasia and cancerGerhild Fabjani, Elisabeth Kucera, Eva Schuster, et al.
Anti-Cancer Drugs|June 4, 2009
Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agentsJanina Hamberger, Manuel Liebeke, Maria Kaiser, et al.
Anticancer Research|October 15, 2010
Two multidrug-resistance (ABCB1) gene polymorphisms as prognostic parameters in women with ovarian cancerChristoph Grimm, Stephan Polterauer, Robert Zeillinger, et al.
Gynecologic Oncology|March 8, 2011
Genetic variations of interleukin-1 and -6 genes and risk of cervical intraepithelial neoplasiaChristoph Grimm, Rafal Watrowski, Konstantin Baumühlner, et al.
Molecular Cancer Research : MCR|June 24, 2005
Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancerPeter Horak, Dietmar Pils, Griet Haller, et al.
Cancer Research|December 20, 2007
Oncogenic BARD1 isoforms expressed in gynecological cancersLin Li, Stephan Ryser, Eva Dizin, et al.
Wiener Klinische Wochenschrift|September 4, 2020
Patient satisfaction after breast cancer surgery : A prospective clinical trialCarmen Leser, Yen Y Tan, Christian Singer, et al.
Pageof 19

Showing results (81-90 of 187) with videos related to

Sort By:
Pageof 19
Journal of the Society for Gynecologic Investigation|October 4, 2005
A common interleukin-6 promoter polymorphism in patients with vulvar cancerChristoph Grimm, Lucia Six, Caroline Tomovski, et al.
Journal of the Society for Gynecologic Investigation|November 26, 2002
Polymorphisms of the interleukin-1 gene cluster and ovarian cancerLukas A Hefler, Elisabeth Ludwig, Antje Lebrecht, et al.
Gynecologic Oncology|October 11, 2005
A polymorphism in the matrix metalloproteinase-1 gene promoter is associated with the prognosis of patients with ovarian cancerLucia Six, Christoph Grimm, Sepp Leodolter, et al.
Cancer Letters|December 14, 2001
Genetic alterations in endometrial hyperplasia and cancerGerhild Fabjani, Elisabeth Kucera, Eva Schuster, et al.
Anti-Cancer Drugs|June 4, 2009
Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agentsJanina Hamberger, Manuel Liebeke, Maria Kaiser, et al.
Anticancer Research|October 15, 2010
Two multidrug-resistance (ABCB1) gene polymorphisms as prognostic parameters in women with ovarian cancerChristoph Grimm, Stephan Polterauer, Robert Zeillinger, et al.
Gynecologic Oncology|March 8, 2011
Genetic variations of interleukin-1 and -6 genes and risk of cervical intraepithelial neoplasiaChristoph Grimm, Rafal Watrowski, Konstantin Baumühlner, et al.
Molecular Cancer Research : MCR|June 24, 2005
Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancerPeter Horak, Dietmar Pils, Griet Haller, et al.
Cancer Research|December 20, 2007
Oncogenic BARD1 isoforms expressed in gynecological cancersLin Li, Stephan Ryser, Eva Dizin, et al.
Wiener Klinische Wochenschrift|September 4, 2020
Patient satisfaction after breast cancer surgery : A prospective clinical trialCarmen Leser, Yen Y Tan, Christian Singer, et al.
Pageof 19